SECsense Logo

Summit Therapeutics Inc. 8-K Report: Key Developments on February 24, 2025

$SMMT
Form 8-K
Filed on: 2025-02-24
Source
Summit Therapeutics Inc. 8-K Report: Key Developments on February 24, 2025

Based on the provided section of the financial report, here are the key pieces of information and insights extracted:

  1. Filing Information:
  • Filing Type: 8-K (current report)
  • Filing Date: February 24, 2025
  1. Company Information:
  • Company Name: Summit Therapeutics Inc.
  • State of Incorporation: Delaware (DE)
  • CIK Number: 0001599298
  • SEC Central Index Key (CIK): 0001599298
  • IRS Employer Identification Number (EIN): 37-1979717
  • Address: 601 Brickell Key Drive, Suite 1000, Miami, FL 33131
  • Phone Number: (305) 203-2034
  1. Stock Information:
  • Common Stock:
    • Par Value: $0.01 per share
    • Ticker Symbol: SMMT
    • Exchange: NASDAQ
  1. Reporting Period:
  • Report Period: The report covers a single day, February 24, 2025.

Insights:

  • The filing is an 8-K form, which indicates that it is used to report unscheduled material events or corporate changes that are of importance to shareholders.
  • Summit Therapeutics Inc. is listed on NASDAQ under the ticker SMMT, which provides context for its market visibility and investor interest.
  • The report specifies a single-day reporting period, which could suggest that this filing relates to a specific event occurring on that date, such as a significant corporate announcement or transaction.
  • The company maintains a corporate office in Miami, Florida, which may indicate its operational focus in that region or potential connections to the biotech industry prevalent in Florida.

This information can be essential for investors, analysts, and stakeholders looking to understand recent developments within Summit Therapeutics Inc. and its market position.